Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 137 clinical trials
Antiplatelet Effects of Low-dose Ticagrelor and Standard-dose Clopidogrel in Chinese ACS Patients

Guideline recommendations on the use of dual antiplatelet therapy have been formulated that ticagrelor 90 mg twice daily plus aspirin in preference to clopidogrel 75mg daily plus aspirin for

antiplatelet therapy
heart disease
clopidogrel
platelet aggregation
aspirin
  • 0 views
  • 08 Nov, 2020
  • 1 location
TAILored Versus COnventional AntithRombotic StratEgy IntenDed for Complex HIgh-Risk PCI

] and aspirin) and late (>6-month post-PCI) deescalated (clopidogrel alone) strategy in patients undergoing high-risk complex PCI as compared with standard Dual Antiplatelet Therapy(aspirin and

percutaneous coronary intervention
aspirin
diabetes
  • 7 views
  • 25 Jun, 2020
  • 13 locations
Optimal antiPlatelet Therapy for High Bleeding and Ischemic RISK Patients Trial

evaluated whether clopidogrel monotherapy reduce the risk of bleeding compared with clopidogrel plus ASA in the following 9 months and achieved non-inferior outcomes in preventing ischemic risk.

  • 8 views
  • 25 Oct, 2020
  • 1 location
Antiplatelet Therapy in Acute Mild-Moderate Ischemic Stroke

The risk of early recurrence or progression of acute ischemic stroke is very high, even in patients treated with aspirin. The Chance study show that clopidogrel plus aspirin treatment reduced

clopidogrel
aspirin
deficit
stroke
transient ischemic attack
  • 4 views
  • 19 Jan, 2020
  • 1 location
Study to Gather Information About the Proper Dosing and Safety of the Oral FXIa Inhibitor BAY 2433334 in Patients Following an Acute Heart Attack

(acetylsalicylic acid +/- clopidogrel) in patients following a recent heart attack (myocardial infarction) that happens when a blood vessel in the heart suddenly becomes blocked. BAY 2433334, works by blocking a

antiplatelet therapy
clopidogrel
aspirin
troponin
ck-mb
  • 57 views
  • 04 Jan, 2021
  • 192 locations
Individualized Antithrombotic Therapy for Patients With Ischemic Cerebrovascular Disease

To investigate the therapeutic effect of individualized treatment of antiplatelet in secondary prevention of ischemic stroke.

aspirin
stroke
  • 1 views
  • 08 Nov, 2020
  • 1 location
Effects of Salvianolate Injection on Myocardial Microcirculation in Patients With Acute STEMI After Primary PCI

To evaluate the influence of Salvianolate injection on myocardial microcirculation perfusion in subjects with STEMI who underwent primary PCI

stemi
  • 0 views
  • 08 Nov, 2020
Balloon Angioplasty for Symptomatic Intracranial Artery Stenosis

Intracranial atherosclerotic disease (ICAD) is the most common cause of ischemical cerebrovascular events. The risk of stroke recurrence or death of ICAD patients remains very high. Even with aggressive medical management including dual antiplatelet therapy and strict management of risk factors, 12.2 percent of patients with 70-99 percent stenosis of …

  • 0 views
  • 01 Jan, 2021
  • 23 locations
Second Enhanced Control of Hypertension and Thrombectomy Stroke Study (ENCHANTED2)

ENCHANTED2 is an international, multicenter, prospective, randomised, open, blinded end-point assessed (PROBE) trial, to assess different approaches to manage blood pressure (BP) in acute ischemic stroke (AIS) patients who have undergone mechanical thrombectomy (MT). There are two nested substudies evaluating different approaches to secondary prevention in this high-risk stroke population.

  • 0 views
  • 26 Aug, 2020
  • 1 location
Comparing Ticagrelor Versus Clopidogrel on Microcirculation

ticagrelor 90 mg twice daily dosing to clopidogrel 75 mg once daily dosing in acute coronary syndrome patients on ASA background, have demonstrated superiority of ticagrelor over clopidogrel in the

clopidogrel 75 mg
clopidogrel
adenosine
plato
ischemia
  • 0 views
  • 08 Nov, 2020
  • 1 location